Emergence and spread of antibiotic resistance: Setting a parameter space

Upsala Journal of Medical Sciences

Volumn 119, Issue 2, 2014, Pages 68-77

  Martínez, José Luis ^a   Baquero, Fernando ^b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Antibiotic resistance; Evolution; Horizontal gene transfer; Resistome

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; GENETICS; HUMAN;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS;

EID: 84900865776     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2014.901444     Document Type: Review

References (99)

1. Upshur RE. Ethics and infectious disease. Bull World Health Organ. 2008;86:654.
2. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature. 1940;146:837.
3. WHO. Overcoming antibiotics resistance. World Health Organization Report on infectious diseases. 2000. Available at: http://www.who.int/infectious- disease-report/index.html
4. World Health Organization. Antimicrobial resistance. 2010. Available at: http://www.who.int/mediacentre/factsheets/fs194/en/.
5. Martinez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother. 2000;44:1771-7.
6. Watanabe T. Infective heredity of multiple drug resistance in bacteria. Bacteriol Rev. 1963;27:87-115.
7. Andam CP, Fournier GP, Gogarten JP. Multilevel populations and the evolution of antibiotic resistance through horizontal gene transfer. FEMS Microbiol Rev. 2011;35:756-67.
8. Boto L, Martinez JL. Ecological and temporal constraints in the evolution of bacterial genomes. Genes. 2011;2:804-28.
9. Sommer MO, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science. 2009;325:1128-31.
10. Davies JE. Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found Symp. 1997;207:15-27.
11. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, Martinez-Solano L, et al. A global view of antibiotic resistance. FEMS Microbiol Rev. 2009;33:44-65.
12. Fajardo A, Linares JF, Martinez JL. Towards an ecological approach to antibiotics and antibiotic resistance genes. Clin Microbiol Infect. 2009;15:14-16.
13. Baquero F, Alvarez-Ortega C, Martinez JL. Ecology and evolution of antibiotic resistance. Environ Microbiol Rep. 2009;1:469-76.
14. Martinez JL. Antibiotics and antibiotic resistance genes in natural environments. Science. 2008;321:365-7.
15. Marcinkeviciene JA, Magliozzo RS, Blanchard JS. Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation. J Biol Chem. 1995;270:22290-5.
16. Balsalobre L, Ferrandiz MJ, Linares J, Tubau F, de la Campa AG. Viridans groupstreptococci aredonors inhorizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother. 2003;47:2072-81.
17. Ferrandiz MJ, Fenoll A, Linares J, De La Campa AG. Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2000;44:840-7.
18. Baquero F, Coque TM, Canton R. Allodemics. Lancet Infect Dis. 2002;2:591-2.
19. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998;351:797-9.
20. Fernandez L, Alvarez-Ortega C, Wiegand I, Olivares J, Kocincova D, Lam JS, et al. Characterization of the polymyxin B resistome of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57:110-19.
21. Martinez JL, Rojo F. Metabolic regulation of antibiotic resistance. FEMS Microbiol Rev. 2011;35:768-89.
22. Alvarez-Ortega C, Wiegand I, Olivares J, Hancock RE, Martinez JL. Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother. 2010;54:4159-67.
23. Fajardo A, Martinez-Martin N, Mercadillo M, Galan JC, Ghysels B, Matthijs S, et al. The neglected intrinsic resistome of bacterial pathogens. PLoS ONE. 2008;3:e1619.
24. Tamae C, Liu A, Kim K, Sitz D, Hong J, Becket E, et al. Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J Bacteriol. 2008;190:5981-8.
25. Breidenstein EB, Khaira BK, Wiegand I, Overhage J, Hancock RE. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother. 2008; 52:4486-91.
26. Girgis HS, Hottes AK, Tavazoie S. Genetic architecture of intrinsic antibiotic susceptibility. PLoS One. 2009;4:e5629.
27. Liu A, Tran L, Becket E, Lee K, Chinn L, Park E, et al. Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother. 2010;54:1393-403.
28. Datta N, Hughes VM. Plasmids of the same Inc groups in Enterobacteria before and after the medical use of antibiotics. Nature. 1983;306:616-17.
29. Benveniste R, Davies J. Aminoglycoside antibioticinactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci USA. 1973;70:2276-80.
30. D'Costa VM, McGrann KM, Hughes DW, Wright GD. Sampling the antibiotic resistome. Science. 2006;311:374-7.
31. Poirel L, Rodriguez-Martinez JM, Mammeri H, Liard A, Nordmann P. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother. 2005;49:3523-5.
32. Canton R, Gonzalez-Alba JM, Galan JC. CTX-M enzymes: origin and diffusion. Front Microbiol. 2012;3:110.
33. Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A. Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother. 2002;46:3045-9.
34. Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MO, Dantas G. The shared antibiotic resistome of soil bacteria and human pathogens. Science. 2012;337:1107-11.
35. Lindberg F, Normark S. Contribution of chromosomal betalactamases to beta-lactam resistance in enterobacteria. Rev Infect Dis. 1986;8:S292-304.
36. Hernandez A, Sanchez MB, Martinez JL. Quinolone resistance: much more than predicted. Front Microbiol. 2011;2:22.
37. Martinez JL, Sanchez MB, Martinez-Solano L, Hernandez A, Garmendia L, Fajardo A, et al. Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev. 2009;33:430-49.
38. Laskaris P, Tolba S, Calvo-Bado L, Wellington L. Coevolution of antibiotic production and counter-resistance in soil bacteria. Environ Microbiol. 2010;12:783-96.
39. Macinga DR, Rather PN. The chromosomal 2'-N-acetyltransferase of Providencia stuartii: physiological functions and genetic regulation. Front Biosci. 1999;4:D132-40.
40. Payie KG, Rather PN, Clarke AJ. Contribution of gentamicin 2'-N-acetyltransferase to the O acetylation of peptidoglycan in Providencia stuartii. J Bacteriol. 1995;177:4303-10.
41. Thanassi DG, Cheng LW, Nikaido H. Active efflux of bile salts by Escherichia coli. J Bacteriol. 1997;179:2512-18.
42. Perez A, Poza M, Fernandez A, Fernandez Mdel C, Mallo S, Merino M, et al. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother. 2012;56:2084-90.
43. Blair JM, Piddock LJ. Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update. Curr Opin Microbiol. 2009;12:512-19.
44. Brown DG, Swanson JK, Allen C. Two host-induced Ralstonia solanacearum genes, acrA and dinF, encode multidrug efflux pumps and contribute to bacterial wilt virulence. Appl Environ Microbiol. 2007;73:2777-86.
45. Evans K, Passador L, Srikumar R, Tsang E, Nezezon J, Poole K. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol. 1998;180:5443-7.
46. Olivares J, Alvarez-Ortega C, Linares JF, Rojo F, Kohler T, Martinez JL. Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks. Environ Microbiol. 2012;14:1968-81.
47. Lamarche MG, Deziel E. MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS ONE. 2011;6:e24310.
48. Kohler T, van Delden C, Curty LK, Hamzehpour MM, Pechere JC. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol. 2001;183:5213-22.
49. Sanchez MB, Martinez JL. Differential epigenetic compatibility of qnr antibiotic resistance determinants with the chromosome of Escherichia coli. PLoS ONE. 2012;7:e35149.
50. Martinez JL, Vicente MF, Delgado-Iribarren A, Perez-Diaz JC, Baquero F. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother. 1989;33:595.
51. Martinez JL, Cercenado E, Rodriguez-Creixems M, Vincente-Perez MF, Delgado-Iribarren A, Baquero F. Resistance to beta-lactam/clavulanate. Lancet. 1987;2:1473.
52. Dantas G, Sommer MO. Context matters - the complex interplay between resistome genotypes and resistance phenotypes. Curr Opin Microbiol. 2012;15:577-82.
53. Gould SJ, Vrba S. Exaptation: a missing term in the science of form. Paleobiology. 1982;8:4-15.
54. Martinez JL. Bottlenecks in the transferability of antibiotic resistance from natural ecosystems to human bacterial pathogens. Front Microbiol. 2011;2:265.
55. Knapp CW, McCluskey SM, Singh BK, Campbell CD, Hudson G, Graham DW. Antibiotic resistance gene abundances correlate with metal and geochemical conditions in archived Scottish soils. PLoS One. 2011;6:e27300.
56. Knapp CW, Dolfing J, Ehlert PA, Graham DW. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ Sci Technol. 2010;44:580-7.
57. Skippington E, Ragan MA. Lateral genetic transfer and the construction of genetic exchange communities. FEMS Microbiol Rev. 2011;35:707-35.
58. Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol. 1999;2:489-93.
59. Linares JF, Lopez JA, Camafeita E, Albar JP, Rojo F, Martinez JL. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol. 2005;187:1384-91.
60. Bjorkman J, Nagaev I, Berg OG, Hughes D, Andersson DI. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science. 2000;287: 1479-82.
61. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010;8: 260-71.
62. Martinez JL. Natural antibiotic resistance and contamination by antibiotic resistance determinants: the two ages in the evolution of resistance to antimicrobials. Front Microbiol. 2012;3:1.
63. Jacquier H, Birgy A, Le Nagard H, Mechulam Y, Schmitt E, Glodt J, et al. Capturing the mutational landscape of the betalactamase TEM-1. Proc Natl Acad Sci USA. 2013;110: 13067-72.
64. Gutkind GO, Di Conza J, Power P, Radice M. betalactamase-mediated resistance: a biochemical, epidemiological and genetic overview. Curr Pharm Des. 2013;19: 164-208.
65. Singh MK, Dominy BN. The evolution of cefotaximase activity in the TEM beta-lactamase. J Mol Biol. 2012;415:205-20.
66. Salverda ML, De Visser JA, Barlow M. Natural evolution of TEM-1 beta-lactamase: experimental reconstruction and clinical relevance. FEMS Microbiol Rev. 2010;34:1015-36.
67. Waksman SA, Woodruff HB. The soil as a source of microorganisms antagonistic to disease-producing bacteria. J Bacteriol. 1940;40:581-600.
68. Linares JF, Gustafsson I, Baquero F, Martinez JL. Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci USA. 2006;103:19484-9.
69. Fajardo A, Martinez JL. Antibiotics as signals that trigger specific bacterial responses. Curr Opin Microbiol. 2008;11:161-7.
70. Yim G, Wang HH, Davies J. Antibiotics as signallingmolecules. Philos Trans R Soc Lond B Biol Sci. 2007;362:1195-200.
71. Yim G, Wang HH, Davies J. The truth about antibiotics. Int J Med Microbiol. 2006;296:163-70.
72. Davies J. Are antibiotics naturally antibiotics? J Ind Microbiol Biotechnol. 2006;33:496-9.
73. Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA. 2002;99:17025-30.
74. Martinez JL. The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc Biol Sci. 2009; 276:2521-30.
75. Aminov RI. Horizontal gene exchange in environmental microbiota. Front Microbiol. 2011;2:158.
76. Baquero F, Tedim AP, Coque TM. Antibiotic resistance shaping multi-level population biology of bacteria. Front Microbiol. 2013;4:15.
77. Samples ME, Byom MJ, Daida JM. Parameter sweeps for exploring parameter spaces of genetic and evolutionary algorithms. In Lobo FJ, Lima CF, Michalewics Z, editors. Parameter setting in evolutionary algorithms. New York: Springer; 2007. pp 161-1854.
78. Del Campo R, Sanchez-Diaz AM, Zamora J, Torres C, Cintas LM, Franco E, et al. Individual variability in fingerto-finger transmission efficiency of Enterococcus faecium clones. Microbiologyopen. 2014;3:128-32.
79. Baquero F, Martinez JL, Canton R. Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol. 2008; 19:260-5.
80. Levin BR, Udekwu KI. Population dynamics of antibiotic treatment: a mathematical model and hypotheses for timekill and continuous-culture experiments. Antimicrob Agents Chemother. 2010;54:3414-26.
81. Levin BR. Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria. PLoS Genet. 2010;6:e1001171.
82. Svara F, Rankin DJ. The evolution of plasmid-carried antibiotic resistance. BMC Evol Biol. 2011;11:130.
83. Thomas I, Nejmeh BA. Definitions of tool integration for environments. IEEE Softw. 1992;9:29-35.
84. Smillie CS, Smith MB, Friedman J, Cordero OX, David LA, Alm EJ. Ecology drives a global network of gene exchange connecting the human microbiome. Nature. 2011;480: 241-4.
85. Lipsitch M, Colijn C, Cohen T, Hanage WP, Fraser C. No coexistence for free: neutral null models for multistrain pathogens. Epidemics. 2009;1:2-13.
86. Nasvall J, Sun L, Roth JR, Andersson DI. Real-time evolution of new genes by innovation, amplification, and divergence. Science. 2012;338:384-7.
87. Perron GG, Lee AE, Wang Y, Huang WE, Barraclough TG. Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations. Proc Biol Sci. 2012;279:1477-84.
88. Olofsson SK, Cars O. Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis. 2007;45: S129-36.
89. Olofsson SK, Geli P, Andersson DI, Cars O. Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli. Antimicrob Agents Chemother. 2005;49:5081-91.
90. Hughes D, Andersson DI. Selection of resistance at lethal and non-lethal antibiotic concentrations. Curr Opin Microbiol. 2012;15:555-60.
91. Gullberg E, Cao S, Berg OG, Ilback C, Sandegren L, Hughes D, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7: e1002158.
92. Andersson DI, Hughes D. Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resist Updat. 2012;15: 162-72.
93. Baquero F, Vicente MF, Perez-Diaz JC. Beta-lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. J Antimicrob Chemother. 1985;15:151-7.
94. Oggioni MR, Furi L, Coelho JR, Maillard JY, Martinez JL. Recent advances in the potential interconnection between antimicrobial resistance to biocides and antibiotics. Expert Rev Anti Infect Ther. 2013;11:363-6.
95. Hernandez A, Ruiz FM, Romero A, Martinez JL. The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog. 2011;7:e1002103.
96. Aiello AE, Larson EL, Levy SB. Consumer antibacterial soaps: effective or just risky? Clin Infect Dis. 2007;45:S137-47.
97. Russell AD. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis. 2003;3:794-803.
98. Fraise AP. Biocide abuse and antimicrobial resistance-a cause for concern? J Antimicrob Chemother. 2002;49:11-12.
99. Sanchez P, Moreno E, Martinez JL. The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother. 2005;49:781-2.